Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention

Abciximab, a platelet glycoprotein (GP) IIb/IIIa inhibitor, has been shown to improve clinical outcomes in patients undergoing percutaneous coronary intervention. However, there is a well-documented increase in bleeding risk associated with the use of this agent. Spontaneous pulmonary hemorrhage is...

Full description

Saved in:
Bibliographic Details
Main Authors: Conley, Maria, Patino, Gilberto, Romick, Benjamin, Almaleh, Michael, Campbell, Charles, Hawkins, Karin, Moore, Scott, Allan, Patrick
Format: Artigo
Language:Inglês
Published: Pulsus Group Inc 2008
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644574/
https://ncbi.nlm.nih.gov/pubmed/18273491
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items